Strategic Drug Discovery Collaborations

Partner with Iktos to identify your next preclinical candidate in less than two years

Our Approach and Success Stories

Our integrated approach combines the strengths of Iktos’s AI technologies and robotics automation to deliver innovative drug candidates at unprecedented speed. We work closely with your team to design, synthesize and test compounds towards the perfect candidate, ensuring a seamless and productive collaboration.

Iktos has collaborated with partners in 60+ projects delivering value in real life programs from hit discovery to lead optimization phases. Our in-house pipeline is an example of how fast we are able to progress towards drug candidate in real life.

Proven Track Record of
Innovation

Our collaborations have led to the successful identification and optimization of numerous drug candidates. Partner with Iktos to benefit from our proven expertise and advanced technologies.

How we work

Our drug discovery process integrates the power of AI and robotics at every step, iterating the DMTA cycle to converge on a Preclinical Drug Candidate in less than 2 years.

Our approach is distinguished by superior chemistry-based Generative AI that produces novel, synthesizable molecules optimized in a Structure-Based Drug Design context; and a unique way of bridging the gap between in silico and in vitro through AI-driven automated synthesis enabled by the integration of all our technological assets into a one-of-its-kind platform.

Technologies

Process

Generative AI for Drug Discovery

Makya

Makya, the first generative AI platform designed by chemists for chemists, streamlines drug discovery by creating diverse, novel, and medchem-like molecules that rapidly converge towards drug candidates.

Discover Makya →

AI-Driven Retrosynthesis

Spaya

Spaya is our cutting-edge AI-driven retrosynthesis platform that transforms target compounds into commercially available starting materials in seconds. With Spaya, you can explore all plausible synthetic routes in real-time, making your research faster and more efficient.

Discover Spaya →

Robot Driven Chemistry

Robotics

Imagine a future where the full Design-Make-Test-Analysis cycle is totally automated.

Discover Robotics →

Hit Discovery

Utilizing Generative AI, synthetic planning, and the Iktos Robotics platform, we efficiently design diverse and novel molecules. Our unique approach gives us access to immense chemical space, providing diverse, very novel, and high-quality compounds rapidly for highly challenging targets.

Hit-to-Lead and Lead Optimization

Fast optimization combining Iktos GenAI’s powerful structure-driven and Multi-Parametric Optimization capabilities with rapid DMTA iterations leveraging Iktos Robotics.

Benefits of Collaboration

Accelerated Discovery

Speed up the identification and optimization of new drug candidates.

Enhanced Efficiency

Improve success rates and reduce the time and cost of drug discovery.

Innovative Solutions

Leverage cutting-edge AI and robotics to explore unique molecular structures and develop innovative therapies for challenging targets.

Want to know more about expertise & approach ?

why iktos

Leading the Way in AI-Driven Drug Discovery

Proven Track Record

Over 60 successful collaborations with leading pharmaceutical, biotech, and academic institutions.

Broad Experience

Expertise across various target families and therapeutic areas, from hit discovery to lead optimization.

Expert Team

A highly skilled team specializing in AI-driven drug design, delivering innovative solutions and valuable results.

Get Started

Partner with Iktos to leverage our advanced technologies and expert support.

Contact us to learn more about our Integrated Drug Discovery Collaborations and how we can help accelerate your drug discovery projects.